Latest Breaking News On - Skye bioscience inc - Page 1 : comparemela.com

Skye writing off glaucoma post-phase II, airs obesity plan

Skye Bioscience (NASDAQ:SKYE) Now Covered by Cantor Fitzgerald

Cantor Fitzgerald started coverage on shares of Skye Bioscience (NASDAQ:SKYE – Free Report) in a research report released on Thursday, Marketbeat reports. The brokerage issued an overweight rating and a $21.00 price target on the stock. SKYE has been the subject of a number of other research reports. Piper Sandler reissued an overweight rating and […]

Skye Bioscience (SKYE) and Its Rivals Financial Analysis

Skye Bioscience (NASDAQ:SKYE – Get Free Report) is one of 1,000 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it compare to its competitors? We will compare Skye Bioscience to similar companies based on the strength of its profitability, dividends, risk, earnings, valuation, institutional ownership and analyst recommendations. Valuation & Earnings This table […]

Skye Bioscience (NASDAQ:SKYE) Posts Earnings Results, Misses Expectations By $0.02 EPS

Skye Bioscience, Inc.'s (NASDAQ:SKYE) last week's 13% decline must have disappointed private equity firms who have a significant stake